The Epidemiological Characteristics and Outcome of COVID-19 in Patients Undergoing Peritoneal Dialysis: A Multi-center Study in Iran.

IF 0.8 4区医学 Q4 UROLOGY & NEPHROLOGY

Iranian journal of kidney diseases Pub Date : 2022-09-01 DOI:10.52547/ijkd.7147

J. Azmandian, Z. Shafii, S. Ezzatzadegan Jahromi, Nader Nourimajalan, S. Seyrafian, A. Atapour, S. Atabak, S. Mazloomzadeh, Z. Norouzi, I. Najafi

{"title":"The Epidemiological Characteristics and Outcome of COVID-19 in Patients Undergoing Peritoneal Dialysis: A Multi-center Study in Iran.","authors":"J. Azmandian, Z. Shafii, S. Ezzatzadegan Jahromi, Nader Nourimajalan, S. Seyrafian, A. Atapour, S. Atabak, S. Mazloomzadeh, Z. Norouzi, I. Najafi","doi":"10.52547/ijkd.7147","DOIUrl":null,"url":null,"abstract":"The pandemic of COVID-19 emerged in December 2019. Although numerous features of the illness have been investigated, the impact of disease on those patients with underlying diseases, is still a major problem. The aim of this multicenter, cohort study, was to determine the clinical manifestations of COVID-19 in peritoneal dialysis (PD) patients. Five hundred and five patients, receiving PD, were enrolled in this study, out of which 3.7% had coronavirus infection. Fever was the most common symptom (63.2%). The hospitalization rate was 10.5, 21.1% required admission to intensive care units (ICU) and the mortality rate was 21%. The most common cause of infection included close contact with the infected individuals and lower rates of protective equipment use. Although the incidence of COVID-19 among PD patients is low, the severity of the disease and the mortality rate are quite high. Vaccination and adherence to preventive measures are strongly recommended in PD patients. DOI: 10.52547/ijkd.7147.","PeriodicalId":14610,"journal":{"name":"Iranian journal of kidney diseases","volume":"16 5 1","pages":"280-283"},"PeriodicalIF":0.8000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iranian journal of kidney diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.52547/ijkd.7147","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}

引用次数: 2

Abstract

The pandemic of COVID-19 emerged in December 2019. Although numerous features of the illness have been investigated, the impact of disease on those patients with underlying diseases, is still a major problem. The aim of this multicenter, cohort study, was to determine the clinical manifestations of COVID-19 in peritoneal dialysis (PD) patients. Five hundred and five patients, receiving PD, were enrolled in this study, out of which 3.7% had coronavirus infection. Fever was the most common symptom (63.2%). The hospitalization rate was 10.5, 21.1% required admission to intensive care units (ICU) and the mortality rate was 21%. The most common cause of infection included close contact with the infected individuals and lower rates of protective equipment use. Although the incidence of COVID-19 among PD patients is low, the severity of the disease and the mortality rate are quite high. Vaccination and adherence to preventive measures are strongly recommended in PD patients. DOI: 10.52547/ijkd.7147.

查看原文本刊更多论文

新冠肺炎腹膜透析患者的流行病学特征和结果：伊朗多中心研究。

新冠肺炎疫情于2019年12月出现。尽管已经对该疾病的许多特征进行了研究，但疾病对那些有潜在疾病的患者的影响仍然是一个主要问题。这项多中心队列研究的目的是确定新冠肺炎在腹膜透析（PD）患者中的临床表现。505名接受帕金森病治疗的患者参与了这项研究，其中3.7%的患者感染了冠状病毒。发热是最常见的症状（63.2%）。住院率为10.5，21.1%需要入住重症监护室（ICU），死亡率为21%。最常见的感染原因包括与感染者的密切接触和防护设备使用率较低。尽管PD患者中新冠肺炎的发病率较低，但疾病的严重程度和死亡率相当高。强烈建议帕金森病患者接种疫苗并遵守预防措施。DOI:10.52547/ijkd.7147。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Iranian journal of kidney diseases UROLOGY & NEPHROLOGY-

CiteScore

2.50

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： The Iranian Journal of Kidney Diseases (IJKD), a peer-reviewed journal in English, is the official publication of the Iranian Society of Nephrology. The aim of the IJKD is the worldwide reflection of the knowledge produced by the scientists and clinicians in nephrology. Published quarterly, the IJKD provides a new platform for advancement of the field. The journal’s objective is to serve as a focal point for debates and exchange of knowledge and experience among researchers in a global context. Original papers, case reports, and invited reviews on all aspects of the kidney diseases, hypertension, dialysis, and transplantation will be covered by the IJKD. Research on the basic science, clinical practice, and socio-economics of renal health are all welcomed by the editors of the journal.